About Stem Nova Network

A Texas-based wholesale supplier of topical cosmetic exosome products and individualized hUCT-MSC for licensed MD, DO, NP and PA practices, built on one idea: every vial should come with the paperwork to show what is in it.

Apply for wholesale accessTalk to our team

2023FoundedSpring, TXHeadquartersB2BLicensed professionals only

Built on personal conviction

We are two brothers who spent our careers in health and wellness. Before Stem Nova Network, we built businesses in the hemp space, working alongside licensed professionals who cared about science-backed products.

In 2023, a serious health challenge in our family introduced us to regenerative biologics firsthand. It moved the field from something we had heard about to the center of our work.

We wanted licensed professionals to have access to products that are rigorously tested, ethically sourced and backed by transparent documentation. Not to make promises about what these products do, but to make sure every vial meets the standard on its paperwork.Dalton & Dillon Worley, Co-Founders
The Worley family, the personal story behind Stem Nova Network
The Worley family.

What we do

Stem Nova Network supplies two product categories, wholesale only, to verified licensed practices.

Topical cosmetic exosomes

  • 3DEXO+ 60B, 12B and Dermal Papillary 150B matrices
  • Nova Core 66B concentrate and the NovaRenew two-step system
  • NTA-verified particle counts on every lot
  • Topical cosmetic use only
Explore exosome biologics →

Individualized hUCT-MSC

  • 25 million umbilical cord tissue-derived MSCs per vial
  • 97% post-thaw viability, independently verified
  • Individualized and not FDA-approved; consult PCP
  • Clinician-directed use
Explore hUCT-MSC →

What drives us

Four principles behind how we source, test and deliver.

Science first
3D bioreactor culture, NTA-verified particle characterization and dual-lab COAs on every lot. We let the documentation speak.
Transparency
Every order ships with lot-specific documentation: COAs, NTA report, sterility and viability data. Ask any supplier for the same, then compare.
Compliance
FDA-registered facility, cGTP-compliant manufacturing (21 CFR Part 1271), and marketing that stays within each product's classification.
Partnership
A dedicated account representative, Biologics Integration Academy training and ongoing compliance support for every approved account.

The people behind Stem Nova

  • Dalton Worley, Co-Founder of Stem Nova Network

    Dalton Worley

    Co-Founder

    Sales leadership, market development and practitioner relationships, with a background building distribution networks in health and wellness.

  • Dillon Worley, Co-Founder of Stem Nova Network

    Dillon Worley

    Co-Founder

    Operations, lab and quality, and compliance review, with a focus on regulatory frameworks and quality systems.

  • Dr. Clay Buchanan, MD, Medical Director of Stem Nova Network

    Dr. Clay Buchanan, MD

    Medical Director

    Board-certified family medicine physician. Reviews product documentation and training content and oversees regulatory compliance.

    About the Medical Director →
  • Mitchell Holzer, VP of Business Development of Stem Nova Network

    Mitchell Holzer

    VP of Business Development

    CPA with 25+ years across banking, M&A, financial services and healthcare. Leads revenue growth, market expansion and strategic partnerships.

  • Jose Allende, Chief Technology Officer of Stem Nova Network

    Jose Allende

    Chief Technology Officer

    Master's in AI from UT with a biochemical-engineering background. Architects Stem Nova's ordering, telehealth and AI platforms.

How we are different

Licensed professionals deserve to know what is in every vial. This is how we deliver on that.

  1. 3D bioreactor culture

    Our manufacturing partner expands cells in 3D bioreactor systems rather than 2D flasks, with NTA-verified particle characterization on every exosome lot. See the science.

  2. Dual-lab COAs

    Every lot is tested by two independent laboratories, and you receive both reports. What we test.

  3. Complete documentation

    No summary sheets. Full COAs, NTA report, sterility and viability data, and storage and handling guidance. How to read a COA.

About Stem Nova Network

More in the full FAQ.

What is Stem Nova Network?

A Texas-based B2B wholesale supplier of topical cosmetic exosome products and individualized hUCT-MSC (human umbilical cord tissue-derived mesenchymal stromal cells), sold only to licensed medical professionals. Stem Nova Network is a DBA of D1D Enterprises, Inc.

Who can purchase from Stem Nova Network?

Licensed MD, DO, NP and PA practices with an active license, operating within their scope of practice. Every application goes through credential verification, typically approved within 24 hours. See how wholesale works.

Where are your products manufactured?

In the USA, in an FDA-registered tissue establishment that is cGTP-compliant (21 CFR Part 1271). For the 25M hUCT-MSC: Wharton's jelly tissue source from AATB-accredited establishment with this tissue category within scope of accreditation.

What documentation comes with each order?

Lot-specific dual-lab Certificates of Analysis, an NTA report for exosome lots, sterility, endotoxin and mycoplasma results, viability data for hUCT-MSC lots, and storage and handling documentation.

Are your products FDA-approved?

No. FDA registration of the manufacturing facility is not FDA approval of any product. Exosome products are topical cosmetic products; hUCT-MSC products are individualized and not FDA-approved.

How do I contact Stem Nova Network?

Apply through the wholesale application, or use our contact page. Our team responds within one business day.

Learn more

Join the Stem Nova Network

Apply for wholesale access to documented, lot-verified biologics. Licensed professionals only; applications are typically approved within 24 hours.

Apply for wholesale accessTalk to our team

For licensed medical professionals only. Exosome products are topical cosmetic products. hUCT-MSC products are individualized and not FDA-approved; use is clinician-directed, and patients should consult their primary care provider. Stem Nova Network does not provide dosing or procedural guidance. Products are not intended to diagnose, treat, cure, or prevent any disease. Stem Nova Network is a DBA of D1D Enterprises, Inc.